• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和抗凝剂在复发性特发性鼻出血中的作用。

Role of age and anticoagulants in recurrent idiopathic epistaxis.

作者信息

Gomes Patrícia, Salvador Pedro, Lombo Catarina, Caselhos Sérgio, Fonseca Rui

机构信息

Department of Otorhinolaryngology, Hospital Senhora da Oliveira, Guimarães, Portugal.

Department of Otorhinolaryngology, Hospital Senhora da Oliveira, Guimarães, Portugal.

出版信息

Acta Otorrinolaringol Esp (Engl Ed). 2020 May-Jun;71(3):160-165. doi: 10.1016/j.otorri.2019.05.003. Epub 2019 Sep 11.

DOI:10.1016/j.otorri.2019.05.003
PMID:31521240
Abstract

OBJECTIVE

Epistaxis is one of the commonest causes of attendance of Otolaryngology emergency rooms. Given its incidence, potential severity and high recurrence rate, a systematic and careful management is mandatory. This work aims to define prognostic factors of epistaxis recurrence.

MATERIAL AND METHODS

Retrospective review of medical records of patients with epistaxis admitted to our emergency department from January 2012 to December 2016. Data of 1005 patients with idiopathic epistaxis were analysed and independent risk factors for recurrence were determined by multiple logistic regression analysis.

RESULTS

Recurrence of epistaxis was found in 303 (30.1%) patients. Patients with recurrent epistaxis were older (p<.001) and more commonly had a history of hypertension (p=.001) and antiplatelet (p=.048) and anticoagulant (p=.001) use than those with episodic epistaxis. Age (adjusted OR 1.21, 95%CI 1.08-1.32, p=.003) and anticoagulant use (adjusted OR 2.68, 95%CI 1.94-3.70, p=.009) were predictors of increased risk of recurrent epistaxis. Gender, alcohol abuse, medical history, active bleeding at admission, unidentified bleeding point or treatment modalities were not associated with recurrence.

CONCLUSION

Age and use of anticoagulation drugs were risk factors for recurrence of epistaxis. None of the previously described risk factors for episodic epistaxis were found to increase the risk of recurrence. Knowledge of factors involved in recurrence might provide important information for assessment and management of increased risk patients.

摘要

目的

鼻出血是耳鼻喉科急诊室最常见的就诊原因之一。鉴于其发病率、潜在严重性和高复发率,必须进行系统且仔细的处理。本研究旨在确定鼻出血复发的预后因素。

材料与方法

回顾性分析2012年1月至2016年12月期间入住我院急诊科的鼻出血患者的病历。分析了1005例特发性鼻出血患者的数据,并通过多因素逻辑回归分析确定复发的独立危险因素。

结果

303例(30.1%)患者出现鼻出血复发。与偶发性鼻出血患者相比,复发性鼻出血患者年龄更大(p<0.001),更常伴有高血压病史(p=0.001),以及使用抗血小板药物(p=0.048)和抗凝药物(p=0.001)。年龄(校正OR 1.21,95%CI 1.08-1.32,p=0.003)和抗凝药物使用(校正OR 2.68,95%CI 1.94-3.70,p=0.009)是鼻出血复发风险增加的预测因素。性别、酗酒、病史、入院时活动性出血、未明确的出血点或治疗方式与复发无关。

结论

年龄和抗凝药物的使用是鼻出血复发的危险因素。未发现先前描述的偶发性鼻出血的危险因素会增加复发风险。了解复发相关因素可能为评估和管理高风险患者提供重要信息。

相似文献

1
Role of age and anticoagulants in recurrent idiopathic epistaxis.年龄和抗凝剂在复发性特发性鼻出血中的作用。
Acta Otorrinolaringol Esp (Engl Ed). 2020 May-Jun;71(3):160-165. doi: 10.1016/j.otorri.2019.05.003. Epub 2019 Sep 11.
2
Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.临床实践指南:鼻出血(鼻衄)执行摘要。
Otolaryngol Head Neck Surg. 2020 Jan;162(1):8-25. doi: 10.1177/0194599819889955.
3
Risk factors for the occurrence of epistaxis: Prospective study.鼻出血发生的危险因素:前瞻性研究。
Auris Nasus Larynx. 2018 Jun;45(3):471-475. doi: 10.1016/j.anl.2017.07.021. Epub 2017 Aug 24.
4
Clinical Practice Guideline: Nosebleed (Epistaxis).临床实践指南:鼻出血(鼻衄)。
Otolaryngol Head Neck Surg. 2020 Jan;162(1_suppl):S1-S38. doi: 10.1177/0194599819890327.
5
Delayed epistaxis in external dacryocystorhinostomy: rate and risk factors.外鼻泪管鼻腔造口术后迟发性鼻出血:发生率及危险因素
Arch Otolaryngol Head Neck Surg. 2010 Feb;136(2):183-6. doi: 10.1001/archoto.2009.200.
6
Risk factors and management outcomes in epistaxis: a tertiary centre experience.鼻出血的危险因素及治疗结果:一家三级中心的经验
ANZ J Surg. 2023 Mar;93(3):555-560. doi: 10.1111/ans.18179. Epub 2022 Dec 20.
7
A retrospective review of spontaneous epistaxis outcomes for patients on novel oral anticoagulants compared to antiplatelets and warfarin.一项关于新型口服抗凝剂使用者与抗血小板药物及华法林使用者的自发性鼻出血结局的回顾性研究。
Am J Otolaryngol. 2022 Jul-Aug;43(4):103488. doi: 10.1016/j.amjoto.2022.103488. Epub 2022 May 4.
8
Management and outcome of epistaxis under direct oral anticoagulants: a comparison with warfarin.直接口服抗凝剂相关鼻出血的管理和结局:与华法林的比较。
Int Forum Allergy Rhinol. 2019 Jan;9(1):120-124. doi: 10.1002/alr.22210. Epub 2018 Oct 3.
9
Risk factors for recurrent epistaxis: importance of initial treatment.复发性鼻出血的危险因素:初始治疗的重要性。
Auris Nasus Larynx. 2014 Feb;41(1):41-5. doi: 10.1016/j.anl.2013.05.004. Epub 2013 Jun 19.
10
Posterior epistaxis: clinical features and acute complications.后鼻孔出血:临床特征与急性并发症
Ann Emerg Med. 1995 May;25(5):592-6. doi: 10.1016/s0196-0644(95)70169-9.

引用本文的文献

1
Factors Associated with Recurrent Emergency Department Visits for Epistaxis in Adults, Cross Sectional Study in Two Tertiary Care Hospitals in Riyadh, Saudi Arabia.沙特阿拉伯利雅得两家三级护理医院的横断面研究:与成人鼻出血反复急诊就诊相关的因素
Ther Clin Risk Manag. 2024 Dec 28;20:955-962. doi: 10.2147/TCRM.S480084. eCollection 2024.
2
Analysis of Bleeding Site to Identify Associated Risk Factors of Intractable Epistaxis.分析出血部位以确定难治性鼻出血的相关危险因素。
Ther Clin Risk Manag. 2021 Aug 12;17:817-822. doi: 10.2147/TCRM.S301706. eCollection 2021.